Enrolled Patients and Study Methods: As of November 15, 2024, the study enrolled a total of 43 patients with non–T315I-mutant CML-CP. These patients received orally administered olverembatinib 40 mg ...
Nat Clin Pract Nephrol. 2006;2(3):136-148. Hypophosphatemia associated with primary hyperparathyroidism is usually of moderate severity; increased urinary phosphate excretion is balanced by ...
Levels of creatine phosphokinase, a muscle damage marker, also decreased by an average of 74% by 12 weeks after gene therapy. This muscle damage marker has remained at lowered levels for up to 18 ...
This participant also presented with folliculitis, which resolved with antibiotic treatment. Participant HS1 experienced a short transient elevation (<3 days) in creatine phosphokinase (CPK) that ...
The ASH Annual Meeting is one of the largest gatherings of the international hematology community, bringing together the most cutting-edge scientific research and latest data of investigational ...
The TEAE that led to discontinuation of the one patient on placebo was blood creatine phosphokinase increased. Currently, there are no disease-modifying therapies approved to treat the full spectrum ...
Rachubinski and colleagues provide an important manuscript that includes two major advances in understanding immune dysregulation in a large cohort of individuals with Down syndrome. The work ...
In terms of serum markers, creatine phosphokinase isoenzyme CK-MB, troponin I (TnI/T) and high-sensitivity C-reactive protein are useful for early myocardial infarction diagnosis. A study of young ...